Neurocrine Biosciences shares owned by Congress Asset Management
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Congress Asset Management
from 13F filings
Historical chart of Congress Asset Management investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Congress Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Congress Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $393k | 2.9k | 137.69 |
| 2023-09-30 | $476k | 4.2k | 112.50 |
| 2023-06-30 | $544k | 5.8k | 94.30 |
| 2023-03-31 | $93M | 920k | 101.22 |
| 2022-12-31 | $110M | 918k | 119.44 |
| 2022-09-30 | $116M | 1.1M | 106.21 |
| 2022-06-30 | $105M | 1.1M | 97.48 |
| 2022-03-31 | $104M | 1.1M | 93.75 |
| 2021-12-31 | $77M | 909k | 85.17 |
| 2021-09-30 | $97M | 1.0M | 95.91 |
| 2021-06-30 | $92M | 949k | 97.32 |
| 2021-03-31 | $88M | 902k | 97.25 |
| 2020-12-31 | $73M | 761k | 95.85 |
| 2020-09-30 | $74M | 768k | 96.16 |